This post was written by Melanie Riehl BMO Capital Markets managing director of biopharma equity research Evan Seigerman joins Market Domination to discuss the best biotech plays outside of the GLP-1 ...

Check the time stamp on this data. Updated AI-Generated Signals for Global Partners Lp Representing Limited Partner Interests ...

(Corrects bullet 2 and paragraph 5 to say drug is being tested along with GLP-1 treatments, not classified as a GLP-1 drug)(Reuters) -Obesity-focused biotech BioAge Labs said on Wednesday it was ...

The GLP-developed warehouses were disposed of due to "the stabilised nature of the portfolio, its attractive quality and ...

In early-stage trials, oral weight-loss drugs from Eli Lilly and Novo Nordisk have shown that they can help patients achieve ...

Prologis is pivoting to AI infrastructure, aiming to capitalize on higher-margin opportunities. Read why I think PLD stock is ...

At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...

(Reuters) - Investment firm Ares Management Corp is in advanced talks to acquire GLP Capital Partners' operations outside China, Bloomberg News reported on Friday, citing people familiar with the ...

Ares Management is in advanced talks to acquire GLP Capital Partners' non-China operations in a deal potentially worth $5B, ...

Ares Management Corp. is in advanced talks on an acquisition of GLP Capital Partners Ltd.’s operations outside of China, ...

Swiss technology firm SoftwareOne Holding is exploring a potential merger with smaller Norwegian competitor Crayon Group Holding, Bloomberg News reported on Friday, citing people familiar with the ...

As technology continues to transform healthcare, cellular remote patient monitoring (RPM)tm solutions are making waves in weight loss management programs. Smart Meter's iScale and iScale Plus can be a ...